Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “IONIZATION CHAMBER”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 829 records · Page 46

Monte Carlo calculations for reference dosimetry of electron beams with the PTW Roos and NE2571 ion chambers

Purpose: To investigate recommendations for reference dosimetry of electron beams and gradient effects for the NE2571 chamber and to provide beam quality conversion factors using Monte Carlo simulations of the PTW Roos and NE2571 ion chambers. Methods: The EGSnrc code system is used to calculate the absorbed dose-to-water and the dose to the gas in fully modeled ion chambers as a function of depth in water. Electron beams are modeled using realistic accelerator simulations as well as beams modeled as collimated point sources from realistic electron beam spectra or monoenergetic electrons. Beam quality conversion factors are calculated with ratios of the doses to water and to the air in the ion chamber in electron beams and a cobalt-60 reference field. The overall ion chamber correction factor is studied using calculations of water-to-air stopping power ratios. Results: The use of an effective point of measurement shift of 1.55 mm from the front face of the PTW Roos chamber, which places the point of measurement inside the chamber cavity, minimizes the difference betweenR{sub 50}, the beam quality specifier, calculated from chamber simulations compared to that obtained using depth-dose calculations in water. A similar shift minimizes the variation of the overall ion chamber correction factor with depth to the practical range and reduces the root-mean-square deviation of a fit to calculated beam quality conversion factors at the reference depth as a function of R{sub 50}. Similarly, an upstream shift of 0.34 r{sub cav} allows a more accurate determination of R{sub 50} from NE2571 chamber calculations and reduces the variation of the overall ion chamber correction factor with depth. The determination of the gradient correction using a shift of 0.22 r{sub cav} optimizes the root-mean-square deviation of a fit to calculated beam quality conversion factors if all beams investigated are considered. However, if only clinical beams are considered, a good fit to results for beam quality conversion factors is obtained without explicitly correcting for gradient effects. The inadequacy of R{sub 50} to uniquely specify beam quality for the accurate selection of k{sub Q} factors is discussed. Systematic uncertainties in beam quality conversion factors are analyzed for the NE2571 chamber and amount to between 0.4% and 1.2% depending on assumptions used. Conclusions: The calculated beam quality conversion factors for the PTW Roos chamber obtained here are in good agreement with literature data. These results characterize the use of an NE2571 ion chamber for reference dosimetry of electron beams even in low-energy beams.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Replacement correction factors for plane-parallel ion chambers in electron beams

Purpose: Plane-parallel chambers are recommended by dosimetry protocols for measurements in (especially low-energy) electron beams. In dosimetry protocols, the replacement correction factor P{sub repl} is assumed unity for ''well-guarded'' plane-parallel chambers in electron beams when the front face of the cavity is the effective point of measurement. There is experimental evidence that ion chambers which are not well-guarded (e.g., Markus) have nonunity P{sub repl} values. Monte Carlo simulations are employed in this study to investigate the replacement correction factors for plane-parallel chambers in electron beams. Methods: Using previously established Monte Carlo calculation methods, the values of P{sub repl} are calculated with high statistical precision for the cavities of a variety of plane-parallel chambers in a water phantom irradiated by various electron beams. The dependences of the values of P{sub repl} on the beam quality, phantom depth, as well as the guard ring width are studied. Results: In the dose fall-off region for low-energy beams, the P{sub repl} values are very sensitive to depth. It is found that this is mainly due to the gradient effect, which originates from the fact that the effective point of measurement for many plane-parallel chambers should not be at the front face of the cavity but rather shifted toward the center of the cavity by a fraction of a millimeter. Using the front face of the cavity as the effective point of measurement, the calculated values of P{sub repl} at d{sub ref} are not unity for some well-guarded plane-parallel chambers. The calculated P{sub repl} values for the Roos chamber are close to 1 for all electron beams. The calculation results for the Markus chamber are in good agreement with the measured values. Conclusions: The appropriate selection of the effective point of measurement for plane-parallel chambers in electron beams is an important issue. If the effective point of measurement is correctly accounted for, the P{sub repl} values would be almost independent of depth. Both the guard ring width and the ratio of the collecting volume diameter to the cavity thickness can influence the values of P{sub repl}. For a diameter to thickness ratio of 5 (e.g., NACP02 chamber), the guard width has to be 6 mm for the chamber to be considered as well-guarded, i.e., have a P{sub repl} value of 1.00.

61 RADIATION PROTECTION AND DOSIMETRY↗

TH-C-19A-07: Output Factor Dependence On Range and Modulation for a New Proton Therapy System

Purpose: Proton treatment planning systems are not able to accurately predict output factors and do not calculate monitor units (MU) for proton fields. Output factors (cGy/MU) for patient-specific fields are usually measured in phantoms or modeled empirically. The purpose of this study is to predict the output factors (OFs) for a given proton (R90) and modulation width (Mod) for the first Mevion S250 proton therapy system. Methods: Using water phantoms and a calibrated ionization chamber-electrometer, over 100 OFs were measured for various R90 and Mod combinations for 24 different options. OFs were measured at the center of the Mod, which coincided with the isocenter. The measured OFs were fitted using an analytic model developed by Kooy (Phys.Med.Biol. 50, 2005) for each option and a derived universal empirical-based polynomial as a function of R90 and Mod for all options. Options are devised for ranges of R90 and Mod. The predicted OFs from both models were compared to measurements. Results: Using the empirical-based model, the values could be predicted to within 3% for at least 90% of measurements and within 5% for 98% of the measurements. Using the analytic model to fit each option with the same effective source position, the prediction is much more accurate. The maximal uncertainty between measured and predicted is within 2% and the averaged root-mean-square is 1.5%. Conclusion: Although the measured data was not exhaustive, both models predicted OFs within acceptable uncertainty. Both models are currently used for a sanity check of our continual patient field OF measurements. As we acquire more patient-field OFs, the model will be refined with an ultimate goal of eliminating the time-consuming patient-specific OF measurements.

60 APPLIED LIFE SCIENCES↗

Biological effect of different IMRT delivery techniques: SMLC, DMLC, and helical tomotherapy

Purpose: Intensity-modulated radiotherapy (IMRT) is delivered using a variety of techniques with differing temporal dose characteristics. Spatial dose metrics are generally used to evaluate treatment plan quality. However, the use of this information alone neglects the effects of the significant differences in dose delivery duration and dose accumulation patterns, both of which can impact cell survival. This study uses the linear-quadratic model with dose protraction corrections to evaluate the biological effectiveness of different IMRT delivery techniques, including fixed gantry IMRT in SMLC (step-and-shoot) and DMLC (sliding window) modes and a rotational IMRT technique (helical tomotherapy) for the treatment of prostate and head/neck sites. Methods: The temporal dose pattern was measured using a small volume ion chamber (A1SL--0.057 cm{sup 3}) to calculate the protraction factor, and biological equivalent dose (BED) was calculated for a range of repair half-times and {alpha}/{beta} ratios. The treatment BED is compared to an ideal delivery of the target prescription dose, in which dose is delivered instantaneously (G(t{sub 0})=1), to evaluate loss in biological effectiveness due to protraction in delivery. In the case of a conventional prescription, the loss in biological effectiveness was further evaluated using published tumor control probability (TCP) data. Results: With SMLC and DMLC IMRT delivery, for both prostate and head/neck, the expected additional loss in BED is about 1% compared to 3D CRT, which corresponds to a predicted 2%-3% reduction in TCP. For tomotherapy, the prostate BED loss is smaller in comparison to 3D CRT; hence, the authors expect a TCP increase of the order of 2%-3%. The aforementioned differences are due to the dose accumulation time. Conclusions: While it is theoretically possible to compensate for changes in biologically effective dose, this would be hindered by large uncertainties in parameters used for such calculations; therefore, it is advantageous to irradiate target volume elements as rapidly as possible. The results of this study indicate that temporal dose delivery pattern is an important component in determining the biological effects of IMRT treatment.

61 RADIATION PROTECTION AND DOSIMETRY↗

SU-C-201-07: Towards Clinical Cherenkov Emission Dosimetry: Stopping Power-To-Cherenkov Power Ratios and Beam Quality Specification of Clinical Electron Beams

Purpose: We propose a Cherenkov emission (CE)-based reference dosimetry method, which in contrast to ionization chamber-based dosimetry, employs spectrum-averaged electron restricted mass collision stopping power-to-Cherenkov power ratios (SCRs), and we examine Monte Carlo-calculated SCRs and beam quality specification of clinical electron beams. Methods: The EGSnrc user code SPRRZnrc was modified to compute SCRs instead of stopping-power ratios (single medium: water; cut-off: CE threshold (observing Spencer-Attix conditions); CE power: Frank-Tamm). SCRs are calculated with BEAMnrc for realistic electron beams with nominal energies of 6–22 MeV from three Varian accelerators (TrueBeam Clinac 21EX, Clinac 2100C/D) and for mono-energetic beams of energies equal to the mean electron energy at the water surface. Sources of deviation between clinical and mono-energetic SCRs are analyzed quantitatively. A universal fit for the beam-quality index R{sub 50} in terms of the depth of 50% CE C{sub 50} is carried out. Results: SCRs at reference depth are overestimated by mono-energetic values by up to 0.2% for a 6-MeV beam and underestimated by up to 2.3% for a 22-MeV beam. The variation is mainly due to the clinical beam spectrum and photon contamination. Beam angular spread has a small effect across all depths and energies. The influence of the electron spectrum becomes increasingly significant at large depths, while at shallow depths and high beam energies photon contamination is predominant (up to 2.0%). The universal data fit reveals a strong linear correlation between R{sub 50} and C{sub 50} (ρ > 0.99999). Conclusion: CE is inherent to radiotherapy beams and can be detected outside the beam with available optical technologies, which makes it an ideal candidate for out-of-beam high-resolution 3D dosimetry. Successful clinical implementation of CE dosimetry hinges on the development of robust protocols for converting measured CE to radiation dose. Our findings constitute a key step towards clinical CE dosimetry.

60 APPLIED LIFE SCIENCES↗

Angular dependence of dose sensitivity of nanoDot optically stimulated luminescent dosimeters in different radiation geometries

Purpose: A type of in vivo dosimeter, an optically stimulated luminescent dosimeter, OSLD, may have dose sensitivity that depends on the angle of incidence of radiation. This work measures how angular dependence of a nanoDot changes with the geometry of the phantom in which irradiation occurs and with the intrinsic structure of the nanoDot. Methods: The OSLDs used in this work were nanoDot dosimeters (Landauer, Inc., Glenwood, IL), which were read with a MicroStar reader (Landauer, Inc., Glenwood, IL). Dose to the OSLDs was delivered by 6 MV x-rays. NanoDots with various intrinsic sensitivities were irradiated in numerous phantoms that had geometric shapes of cylinders, rectangles, and a cube. Results: No angular dependence was seen in cylindrical phantoms, cubic phantoms, or rectangular phantoms with a thickness to width ratio of 0.3 or 1.5. An angular dependence of 1% was observed in rectangular phantoms with a thickness to width of 0.433–0.633. A group of nanoDots had sensitive layers with mass density of 2.42–2.58 g/cm{sup 3} and relative sensitivity of 0.92–1.09 and no difference in their angular dependence. Within experimental uncertainty, nanoDot measurements agree with a parallel-plate ion chamber at a depth of maximum dose. Conclusions: When irradiated in cylindrical, rectangular, and cubic phantoms, nanoDots show a maximum angular dependence of 1% or less at an incidence angle of 90°. For a sample of 78 new nanoDots, the range of their relative intrinsic sensitivity is 0.92–1.09. For a sample of ten nanoDots, on average, the mass in the sensitive layer is 73.1% Al{sub 2}O{sub 3}:C and 26.9% polyester. The mass density of the sensitive layer of a nanoDot disc is between 2.42 and 2.58 g/cm{sup 3}. The angular dependence is not related to Al{sub 2}O{sub 3}:C loading of the nanoDot disc. The nanoDot at the depth of maximum dose has no more angular dependence than a parallel-plate ion chamber.

60 APPLIED LIFE SCIENCES↗

Spectral Shifting in Nondestructive Assay Instrumentation

This project involves spectrum tailoring research that endeavors to better distinguish energies of gamma rays using different spectral material thicknesses and determine neutron energies by coating detectors with various materials.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

Measurement of the longitudinal diffusion of ionization electrons in the MicroBooNE detector

Accurate knowledge of electron transport properties is vital to understanding the information provided by liquid argon time projection chambers (LArTPCs). Ionization electron drift-lifetime, local electric field distortions caused by positive ion accumulation, and electron diffusion can all significantly impact the measured signal waveforms. This paper presents a measurement of the effective longitudinal electron diffusion coefficient, D L , in MicroBooNE at the nominal electric field strength of 273.9 V/cm. Historically, this measurement has been made in LArTPC prototype detectors. This represents the first measurement in a large-scale (85 tonne active volume) LArTPC operating in a neutrino beam. This is the largest dataset ever used for this measurement. Using a sample of ~70,000 through-going cosmic ray muon tracks tagged with MicroBooNE's cosmic ray tagger system, we measure D L = 3.74 +0.28 -0.29 cm 2 /s.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗

Fission fragment mass and energy distributions as a function of incident neutron energy measured in a lead slowing-down spectrometer

A new method of measuring fission fragment mass and energy distributions as a function of incident neutron energy in the range from below 0.1 eV to 1 keV has been developed. The method involves placing a double-sided Frisch-gridded fission chamber in Rensselaer Polytechnic Institute's lead slowing-down spectrometer (LSDS). The high neutron flux of the LSDS allows for the measurement of the energy-dependent, neutron-induced fission cross sections simultaneously with the mass and kinetic energy of the fission fragments of various small samples. The samples may be isotopes that are not available in large quantities (submicrograms) or with small fission cross sections (microbarns). The fission chamber consists of two anodes shielded by Frisch grids on either side of a single cathode. The sample is located in the center of the cathode and is made by depositing small amounts of actinides on very thin films. The chamber was successfully tested and calibrated using 0.41+-0.04 ng of {sup 252}Cf and the resulting mass distributions were compared to those of previous work. As a proof of concept, the chamber was placed in the LSDS to measure the neutron-induced fission cross section and fragment mass and energy distributions of 25.3+-0.5 mug of {sup 235}U. Changes in the mass distributions as a function of incident neutron energy are evident and are examined using the multimodal fission mode model.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Neutron-induced fission cross section of {sup nat}Pb and {sup 209}Bi from threshold to 1 GeV: An improved parametrization

Neutron-induced fission cross sections for {sup nat}Pb and {sup 209}Bi were measured with a white-spectrum neutron source at the CERN Neutron Time-of-Flight (n{sub T}OF) facility. The experiment, using neutrons from threshold up to 1 GeV, provides the first results for these nuclei above 200 MeV. The cross sections were measured relative to {sup 235}U and {sup 238}U in a dedicated fission chamber with parallel plate avalanche counter detectors. Results are compared with previous experimental data. Upgraded parametrizations of the cross sections are presented, from threshold energy up to 1 GeV. The proposed new sets of fitting parameters improve former results along the whole energy range.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

SU-E-T-260: Pediatric Total Body Irradiation Calculations and In-Vivo Dosimetry Using Diodes and OSLD's

Purpose: To verify that a photon total body irradiation (TBI) calculation method scales properly from adult to pediatric dimensions and to determine TBI in-vivo dosimetry correction factors for diodes and optically stimulated luminescent dosimeters (OSLD's). Methods: TBI technique used is 400 SAD 18 MV opposed laterals with beam spoiler. Water bags are used to supplement narrower lateral dimensions for patient treatments. To verify that dose calculations scale properly with decreasing dimensions, CAX doses were measured and compared to calculations for different rectangular phantom geometries: (L=length(cm), H=height(cm), d=depth(cm)): L(30)xH(30) (d=3-25), L(30)xH(12)(d=2–20), L(13)xH(13) (d=5–13), L(30)x(H=10–40) d=15, L(30–150) x H(10) (d=15). In infant geometry, measured off axis “leg” dose (L(30)xH(2.5–10.6), d=7)) was compared to CAX (“body” L(30)xH(10)(d=7) adjacent to “leg”). Entrance and exit doses were measured with surface diodes, diodes with buildup, OSLD's, as well as ion chambers for comparison. Correction factors ((ion chamber CAX dose)/(in vivo dose)) were calculated for surface diodes, diodes with buildup, OSLD's, and ion chamber. Results: All rectangular phantom measurements agree with calculated within 2.5%. For L(30)xH(30), L(30)xH(12), L(13)xH(13), L(30)x(H=10–40) and L(30–80)xH(10) agreement was within 1%. For the infant geometry, the ratio of leg dose to CAX varies from 0.956 (h=2.5) to 0.995 (h=10.6). The range of in-vivo dosimetry entrance+exit to CAX dose correction factors varied by dosimeter (diode: 0.883–1.015, surface diode: 1.008–1.214, ion chamber: 0.924–1.084, OSLD: 0.920–1.106). Conclusion: TBI calculations scaled properly to pediatric dimensions. In-vivo dosimetry with various detectors demonstrated similar trends with different magnitudes. OSLD measurements agreed well with ion chamber measurements.

60 APPLIED LIFE SCIENCES↗

SU-E-T-377: Evaluation of a Novel Transmission Detector as a Reference Chamber for Use in Beam Measurements

Purpose: To evaluate a new transmission chamber for use as a reference chamber in measurements of beam data Methods: We assessed the performance of a new transmission detector, the Stealth Chamber, manufactured by IBA (IBA Dosimetry). The chamber has an active volume of 249 cm{sup 3}, with an attenuation equivalent of <0.5mm Al. We mounted the chamber to a TrueBeam linac (Varian Medical Systems, Palo Alto, CA) such that the active area is perpendicular to the beam direction. We performed PDD and profile measurements on field sizes from 1×1 cm{sup 2} to 10×10 cm{sup 2}, as well as for a 4 mm cone. The field detector was either a CC-13 chamber (IBA Dosimetry) with an active volume of 0.13 cm{sup 3} or an Edge Detector (Sun Nuclear, Melbourne, FL) with an active volume of 0.019 cm{sup 3}. For comparison we repeated all measurements using a CC-13 or CC-01 (active volume 0.01 cm{sup 3} ) chamber as reference detectors (IBA Dosimetry).All scans were acquired using a Blue Phantom2 (IBA Dosimetry) and IBA OmniPro-Accept v7.4.24 software. Results: All measurements with the Stealth Chamber were identical to those with ion reference chambers. For both regular and filter free 6MV beams there was agreement in PDDs and profiles, including the penumbra region, for all field sizes. This was true for the 4mm cone measurement, as well. The deviation between the Stealth and ion chamber measurements was on average 0.3%. Conclusion: The Stealth Chamber gives identical beam data as a conventional ion chamber for all field sizes. The advantage of the Stealth chamber over ion chambers is its efficiency. Once mounted, there is no need to reposition the chamber with varying field sizes. This translates into a huge savings in measurement time, as well as a reduction in potential errors due to reference chamber mispositioning.

43 PARTICLE ACCELERATORS↗

Dosimetric properties of an amorphous-silicon EPID used in continuous acquisition mode for application to dynamic and arc IMRT

Dosimetric properties of an amorphous-silicon electronic portal imaging device (EPID) operated in a real-time acquisition mode were investigated. This mode will be essential for time-resolved dose verification of dynamic (sliding window) intensity modulated radiation therapy (IMRT) and intensity modulated arc radiation therapy (arc-IMRT). The EPID was used in continuous acquisition mode (i.e., ''cine'' mode) where individual sequential image frames are acquired in real time. The properties studied include dose linearity, reproducibility of response, and image stability. Results of using the continuous acquisition mode with several example treatments including dynamic IMRT, arc treatment, and single-arc-IMRT are compared to results using the well-studied integrated acquisition mode (i.e., ''frame averaging'' or ''IMRT'' mode). Real-time EPID response was also compared to real-time ion-chamber data for selected points in the deliveries. The example treatment deliveries in both continuous and integrated acquisition modes were converted to arbitrary EPID dose units via a calibration field. The summation of all acquired continuous mode images was compared using percentage dose difference to the single image acquired in the integrated mode using in-field pixels only (defined as those pixels >10% of maximum, in-field signal). Using the continuous acquisition mode, the EPID response was not linear with dose. It was found that the continuous mode dose response corresponded approximately to dropping one image per acquisition session. Reproducibility of EPID response to low monitor units (MUs) was found to be poor but greatly improved with increasing MU. Open field profiles were found to be stable in the cross-plane direction but required several frames to become stable in the in-plane direction. However, both of these issues are clinically insignificant due to arc-IMRT deliveries requiring relatively large monitor units (>100 MU). Analysis of the five IMRT, arc, and arc-IMRT tests revealed that all examples compared to within 2% of maximum dose for more than 95% of in-field pixels. The continuous acquisition mode is suited to time-resolved dosimetry applications including arc-IMRT and dynamic IMRT, giving comparable dose results to the well-studied integrated acquisition mode, although caution should be used in low MU applications. Time-resolved EPID dose information also compared well to time-resolved ion-chamber measurements.

61 RADIATION PROTECTION AND DOSIMETRY↗

SU-E-T-406: Evaluation of the Stealth Chamber by IBA Under Large Field Conditions

Purpose: To evaluate the performance of the stealth chamber by IBA under large field conditions. Methods: Measurement of PDDs and profiles for fields of 10×10, 15×15, 20×20 and 25×25 cm2 were acquired in a blue phantom2 scanning system for 6 and 15 MV beams in a Varian TrueBeam linear accelerator. The stealth chamber has a field size limit of 25×25 cm2. Measurements with two different detector set were performed. First a cc13 chamber as field and reference chamber was acquired. And with a cc13 chamber as field detector and the stealth chamber as the reference chamber. PDDs for the fields mentioned above were conducted and profiles with the same fields at depth of dmax, 5, 10 and 20 cm were acquired for comparison. Results: Examination of the PDDs and profile comparison with a criterion of 1% and 1 mm agreement was performed. Very good agreement between the cc13 and stealth chamber set was observed within the chosen criterion. Conclusion: This work indicates the comparable results obtained with the use of the stealth chamber and cc13 as the reference chamber in relative dosimetry measurements.

43 PARTICLE ACCELERATORS↗

SU-E-T-228: Liquid Ionisation Chamber Array and MicroDiamond Measurements with the CyberKnife System

Purpose: The aim of this study was to measure the dose profile and output factors with a CyberKnife accelerator using a TM60019 microDiamond detector and a 1000SRS liquid chamber array (both PTW Freiburg, Germany). Methods: An MP3 water phantom (PTW, Freiburg) was positioned along the robotic world coordinate system. The TM60019 detector was adjusted to the center of the according fields and the semiconductor axis was aligned with the beam direction. Profiles at 5cm water depth and SSD = 80 cm were measured along the robotic x axis and y axis for the cylindrical collimators of the CyberKnife (diameter 60, 50, 40, 30, 20, 15, 12.5, 10, 7.5 and 5mm). To determine the output factors the dose profile was measured at 0.1 mm steps around the field center to find the maximum dose value. The liquid chamber array (1000SRS) measurement was performed with the same setup, but with RW3 buildup. Results: The 1000SRS measurements closely conform with the TM60019 profile measurement in all profile regions and for all collimator sizes. The profile measurement is influenced by the almost equal spatial resolution of the TM60019 detector (radius of the sensitive area 1.1mm) and of the 1000SRS liquid chamber array (single chamber width 2.3mm). The measured dose profiles have not been corrected for this limited spatial resolution. Rather we purpose to consider that spatial dose averaging over 2 mm wide regions might be justified in view of patient positioning inaccuracies and of the spaces in tissue participating in the biological radiation responses. Conclusion: The 1000SRS data points conform with the TM60019 profile measurements at all profile regions showing the applicability of liquid ion chamber arrays with the CyberKnife system.

60 APPLIED LIFE SCIENCES↗